InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
9
T+90 hit rate
0%
T+90 mean return
-24.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Morrell Martha, Directeur Médical. Officer active across 1 company, notably NeuroPace Inc. Cumulatively, 27 disclosures have been recorded. Breakdown: 0 buy · 9 sells. Total volume traded: €1.5m. Activity tracked since 4 June 2021. The latest transaction was filed on 24 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations27 total
335 sharesCommon StockSEC:0001855616-26-000019:0
1,341 shares@ US$13.270.9% of flowCommon StockSEC:0001855616-26-000011:0
357 shares@ US$8.88Common StockSEC:0001415889-25-023213:0
3,052 shares@ US$8.661.3% of flowCommon StockSEC:0001415889-25-022748:0
1,338 shares@ US$13.541.0% of flowCommon StockSEC:0001415889-25-016077:0
3,051 shares@ US$17.993.0% of flowCommon StockSEC:0001415889-25-014013:0
237 shares@ US$10.940.1% of flowCommon StockSEC:0001415889-25-011241:0
11,700 shares0Common StockSEC:0001415889-25-008864:0
1,337 shares@ US$11.810.9% of flowCommon StockSEC:0001415889-25-006924:0
1,430 shares@ US$12.561.0% of flowCommon StockSEC:0001415889-25-006142:0
50,000 shares@ US$0.0260.1% of flowCommon StockSEC:0001415889-25-005576:0
926 shares@ US$8.320.4% of flowCommon StockSEC:0001415889-25-005571:0
78,334 shares@ US$13.721362.6% of flowCommon StockSEC:0001415889-25-005577:0
100 shares@ US$15.000.1% of flowCommon StockSEC:0001415889-25-002590:0
3,200 shares@ US$15.012.8% of flowCommon StockSEC:0001415889-25-002207:0
12,500 shares0Common StockSEC:0001209191-24-004089:0
14,143 shares@ US$15.069112.0% of flowCommon StockSEC:0001209191-24-002942:0
11,262 shares@ US$15.09549.6% of flowCommon StockSEC:0001209191-24-002596:0
827 shares@ US$15.0250.7% of flowCommon StockSEC:0001209191-24-002322:0
102 shares@ US$10.000.1% of flowCommon StockSEC:0001209191-23-059946:0
2,730 shares@ US$10.14481.5% of flowCommon StockSEC:0001209191-23-059564:0
11,005 shares@ US$8.15755.1% of flowCommon StockSEC:0001209191-23-057715:0
80,000 shares0Common StockSEC:0001209191-23-011946:0
192 shares@ US$0.0260.0% of flowCommon StockSEC:0001209191-22-053273:0
46,760 shares0Common StockSEC:0001209191-22-016874:0
25 of 27 declarations
About Morrell Martha
Martha Morrell is the Chief Medical Officer at NeuroPace Inc. In this role, she is responsible for the medical direction and health initiatives of the company. Her expertise is essential for developing innovative health solutions.
